Promentis Pharmaceuticals' Series A Round

Promentis Pharmaceuticals raised a round of funding on February 11, 2010.

Promentis Pharmaceuticals is a pharmaceutical company developing compounds for the treatment of schizophrenia and other central nervous system disorders. Promentis' drug development efforts are focuse…

Articles about Promentis Pharmaceuticals' Series A Round: